Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Elicio Therapeutics (ELTX) EBT Margin (2020 - 2022)

Elicio Therapeutics filings provide 3 years of EBT Margin readings, the most recent being 1117.76% for Q2 2022.

  • On a quarterly basis, EBT Margin rose 226075.0% to 1117.76% in Q2 2022 year-over-year; TTM through Mar 2023 was 4329.56%, a 421194.0% decrease, with the full-year FY2022 number at 1184.92%, down 104202.0% from a year prior.
  • EBT Margin hit 1117.76% in Q2 2022 for Elicio Therapeutics, down from 878.94% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 621.63% in Q4 2020 to a low of 5374.39% in Q1 2021.
  • Median EBT Margin over the past 3 years was 1117.76% (2022), compared with a mean of 1657.64%.
  • Biggest five-year swings in EBT Margin: plummeted -100966bps in 2021 and later soared 449545bps in 2022.
  • Elicio Therapeutics' EBT Margin stood at 621.63% in 2020, then crashed by -91bps to 58.22% in 2021, then tumbled by -2020bps to 1117.76% in 2022.
  • The last three reported values for EBT Margin were 1117.76% (Q2 2022), 878.94% (Q1 2022), and 58.22% (Q4 2021) per Business Quant data.